Recombinant multi-species Galectin 10/CLC protein for cell curture, in vitro study, in vivo study, benchmark, drug discovery & MOA research and positive control for the diagnosis

Genemedi produces recombinant Human, Cynomolgus/ Rhesus macaque, Rat, Mouse, Feline, Canine, Bovine, Equine Galectin 10/CLC protein for cell curture, in vitro study, in vivo study, benchmark, drug discovery & MOA research and positive control for the diagnosis.
Lysophospholipases are enzymes that act on biological membranes to regulate the multifunctional lysophospholipids. The protein encoded by this gene is a lysophospholipase expressed in eosinophils and basophils. It hydrolyzes lysophosphatidylcholine to glycerophosphocholine and a free fatty acid. This protein may possess carbohydrate or IgE-binding activities. It is both structurally and functionally related to the galectin family of beta-galactoside binding proteins. It may be associated with inflammation and some myeloid leukemias. [provided by RefSeq, Jul 2008]
The Alternative Names of target: CLC,Charcot-Leyden crystal protein (CLC),Eosinophil lysophospholipase,GAL10,Gal-10,Galectin 10,Galectin-10,LGALS10,LGALS10A,LPPL_HUMAN,Lysolecithin acylhydrolase

Target products collectionGo to Galectin 10/CLC products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)

pdfMSDSpdfCOApdfDatasheet

Product information

Catalog No. Product Name Species Reactivity
GM-Tg-hg-IP4282-Ag-1/ GM-Tg-hg-IP4282-Ag-2 Human Galectin 10/CLC protein Human
GM-Tg-rg-IP4282-Ag-1/ GM-Tg-rg-IP4282-Ag-2 Rat Galectin 10/CLC protein Rat
GM-Tg-mg-IP4282-Ag-1/ GM-Tg-mg-IP4282-Ag-2 Mouse Galectin 10/CLC protein Mouse
GM-Tg-cynog-IP4282-Ag-1/ GM-Tg-cynog-IP4282-Ag-2 Cynomolgus/Rhesus macaque Galectin 10/CLC protein Cynomolgus/ Rhesus macaque
GM-Tg-felg-IP4282-Ag-1/ GM-Tg-felg-IP4282-Ag-2 Feline Galectin 10/CLC protein Feline
GM-Tg-cang-IP4282-Ag-1/ GM-Tg-cang-IP4282-Ag-2 Canine Galectin 10/CLC protein Canine
GM-Tg-bovg-IP4282-Ag-1/ GM-Tg-bovg-IP4282-Ag-2 Bovine Galectin 10/CLC protein Bovine
GM-Tg-equg-IP4282-Ag-1/ GM-Tg-equg-IP4282-Ag-2 Equine Galectin 10/CLC protein Equine

Size： 1mg | 10mg | 100mg



Product Description

Catalog No. GM-Tg-hg-IP4282-Ag-1/ GM-Tg-hg-IP4282-Ag-2; GM-Tg-rg-IP4282-Ag-1/ GM-Tg-rg-IP4282-Ag-2;
GM-Tg-mg-IP4282-Ag-1/ GM-Tg-mg-IP4282-Ag-2; GM-Tg-cynog-IP4282-Ag-1/ GM-Tg-cynog-IP4282-Ag-2;
GM-Tg-felg-IP4282-Ag-1/ GM-Tg-felg-IP4282-Ag-2; GM-Tg-cang-IP4282-Ag-1/ GM-Tg-cang-IP4282-Ag-2;
GM-Tg-bovg-IP4282-Ag-1/ GM-Tg-bovg-IP4282-Ag-2; GM-Tg-equg-IP4282-Ag-1/ GM-Tg-equg-IP4282-Ag-2
Products Name Galectin 10/CLC protein
Species Human, Cynomolgus/ Rhesus macaque, rat, mouse, Feline, Canine, Bovine, Equine
Target Name Galectin 10/CLC
Protein Sub-location Introcelluar Protein
Isotypes Recombinant protein
Expression platform Mammalian cell
Bioactivity validation Affintiy&bioactivity validated by ELISA, cell culture validated.
Tag His
Products description Recombinant Human, Cynomolgus/ Rhesus macaque, Rat, Mouse, Feline, Canine, Bovine, Equine Galectin 10/CLC protein was expressed in mammalian cell expression system and is expressed with 6 HIS tag at the C-terminus for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic).
Purity Purity: ≥95% (SDS-PAGE)
Application In vitro study, in vivo study, benchmark, positive control for the diagnosis. Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation & Reconstitution Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4);
For PSB2, reconstituted with 0.9% sodium chloride;
For PBS, reconstituted with ddH2O.
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference






    About Gmab

    GDU
    GDU

    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.
    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.